NCT05522387 2026-02-27An Open-Label Extension of XPro1595 in Patients With Alzheimer's DiseaseInmune Bio, Inc.Phase 2 Terminated11 enrolled
NCT05504681 2026-02-17Integration of Neurocognitive Biomarkers Into a Neuro-Oncology ClinicBaptist Health South FloridaRecruiting200 enrolled